Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2019-12-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition and changes in share ownership by 'Dec 1st Fund' (디셈버 1호조합) in the company 'Lumi Micro' (루미마이크로). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels.
2019-12-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares and convertible bonds by '푸른1호조합' (Purun No. 1 Fund) in '루미마이크로(주)' (Lumi Micro Co., Ltd.), crossing the 5% ownership threshold. This falls under the category of Major Shareholding Notification.
2019-12-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the acquisition and disposal of shares by a specific entity (NIKE 3rd Fund) in a listed company (Lumi Micro). This falls under the category of Major Shareholding Notification.
2019-12-10 Korean
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득(제5회)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the 'acquisition of bonds before maturity' (specifically, a Bond with Warrant/BW) by the company Lumimicro. It details the specific bond series, the reason for early redemption (put option), the amount acquired, and the method of acquisition. This falls under capital structure changes and financing updates related to debt instruments, which is best classified as a Capital/Financing Update (CAP).
2019-12-09 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'Lumi Micro'. It outlines the date, location, and agenda items (election of directors and amendment of articles of incorporation). In the context of corporate filings, a notice of a meeting to shareholders to request votes or provide information for an upcoming meeting is classified as a Proxy Solicitation & Information Statement (PSI).
2019-12-05 Korean
주주명부폐쇄기간또는기준일설정
AGM Information Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Extraordinary General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notice of a corporate action. Given it is a standard regulatory disclosure filed with the KRX (Korea Exchange) that does not fit into specific categories like dividends or share buybacks, it is classified as a general regulatory filing.
2019-12-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.